long covid

New CDC Foundation Program Focuses on Creating Partnerships to Address Chronic Conditions Caused by Infections, Including Long COVID...

Abstract Persistent symptoms after acute COVID-19 infection, termed post-COVID-19 fatigue, occur in 44–70% of patients. Characterizing fatigue in this population is vital to determine the etiology of post-COVID-19 fatigue symptoms and to assess the effectiveness of potential interventions...

Full title: Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness Open access: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799116 Question How do patient-reported physical, mental, and social well-being compare...

Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes Hao Zhang, Chengxi Zang, Zhenxing Xu, Yongkang Zhang, Jie Xu, Jiang Bian, Dmitry Morozyuk, Dhruv Khullar, Yiye Zhang, Anna S. Nordvig, Edward J. Schenck, Elizabeth A. Shenkman, Russell L. Rothman, Jason P. Block, Kristin...

Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19 Andre Figueiredo Rendeiro, Hiranmayi Ravichandran, Junbum Kim, Alain Borczuk, Olivier Elemento, Robert Edward Schwartz SARS-CoV-2 infection can manifest as a wide range of respiratory and systemic...

Abstract Background To update and internally validate a model to predict children and young people (CYP) most likely to experience long COVID (i.e. at least one impairing symptom) 3 months after SARS-CoV-2 PCR testing and to determine whether the impact of predictors differed by SARS-CoV-2...

https://thorax.bmj.com/content/77/Suppl_1/A2.1.abstract Abstract Introduction and Objectives Neutrophils are increasingly recognised for a role in acute COVID19, contributing to hyperinflammatory responses, immunothrombosis and tissue damage. However, less is known about the cellular changes...

Financial Times article: Blood clot drug totally ineffective as post-Covid treatment, research finds Results from UK-wide trials on anticoagulant Apixaban set to change protocols around the world A drug to reduce blood clots, widely prescribed to Covid-19 patients after discharge from hospital...

Abstract Background Stigma can be experienced as perceived or actual disqualification from social and institutional acceptance on the basis of one or more physical, health-related, behavioural, or other attributes deemed to be undesirable. Long COVID is a predominantly multisystem condition...

Preprint See post 5 for published version Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer’s disease individuals Elizabeth Griggs, Kyle Trageser, Sean Naughton, Eun-Jeong Yang, Brian Mathew, Grace Van Hyfte, Linh Hellmers, Nathalie Jette, Molly Estill, Li Shen, Tracy...

Tevogen Bio is set to study the potential therapeutic use of its investigational Covid-19 T cell therapy, TVGN-489, in long Covid. The finding that none of the patients in the TVGN 489 proof-of-concept (POC) trial, treated for their initial Covid infection, developed long Covid to date is...

CHICAGO — Using a special type of MRI, researchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA). About one in five adults...

Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic https://www.frontiersin.org/articles/10.3389/fpsyg.2022.1022203/full

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic demands reliable prognostic models for estimating the risk of long COVID. We developed and validated a prediction model to estimate the probability of known common long COVID symptoms at least 60 days after acute COVID-19...

ME/CFS and Long COVID: Q&A With the CDC's Dr Jennifer Cope https://www.medscape.com/viewarticle/984122

http://www.geneuro.com/fr/patients-fr/francais The GNC-501 study, titled “Temelimab as a Disease Modifying Therapy in Patients with Neurological, Neuropsychological, and Psychiatric Symptoms in Post-COVID-19 or Post-Acute Sequelae of COVID-19 (PASC) Syndrome,” will enroll 200 patients from...

Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study Etter MM, Martins TA, Kulsvehagen L, Pössnecker E, Duchemin W, Hogan S, Sanabria-Diaz G, Müller J, Chiappini A, Rychen J, Eberhard N, Guzman R, Mariani L...

Increasing evidence suggests persistent cognitive dysfunction after COVID-19. In this cross-sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using tailored eye tracking assessments. Individuals who recovered from COVID-19 made significantly...